An international team of researchers, including Miller School pulmonologist Marilyn K. Glassberg, M.D., has confirmed the results of earlier trials that pirfenidone, a medication already approved for use in nearly three dozen countries, is effective in slowing the progress of idiopathic pulmonary fibrosis. Their findings were published in the May 20 issue of The New England Journal of Medicine.
A new Miller School research study has identified a safe and effective route for delivering stem cells to the brain, where they can potentially repair stroke-damaged tissue. "Our team found that delivering a low dose of mesenchymal stem cells (MSCs) through the carotid artery at 24 hours after stroke resulted in effective therapy for ischemic stroke in an animal model," said lead author Dileep Yavagal, M.D.
Driven by a commitment to move from treatments to cures, the University of Miami Miller School of Medicine is a leader in the field of regenerative medicine. Researchers and clinicians are collaborating in a wide range of disciplines to develop new strategies that use the body’s own cells to fight cancer, diabetes, heart disease and other chronic problems, as well as repair damaged nerve fibers.